2024³â °ºÏ»ï¼ºº´¿ø Á¤½Å°Ç°ÀÇÇаú Çмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-02-24
±³À°ÀÏÀÚ : 2024-02-24
±³À°Àå¼Ò : Çѱ¹ÇÁ·¹½º¼¾ÅÍ
±³À°ÁÖÁ¦ : 2024³â °ºÏ»ï¼ºº´¿ø Á¤½Å°Ç°ÀÇÇаú Çмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : °ºÏ»ï¼ºº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¤½Å°Ç°ÀÇÇаú
´ã´çÀÚ : ¾çÇý·Ã
¿¬¶ôó : 02-2001-2803
À̸ÞÀÏ : hyeryun.yang@samsung.com
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í »çÀü°áÁ¦, ÇöÀå°áÁ¦ : 5¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 15:30~15:40 °³È¸»ç ½ÉÁøÇö(»ç°ú³ª¹« Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 15:40~16:05 ¾ËÃ÷ÇÏÀ̸Ӻ´ ÃֽŠÁø´Ü ±â¹ý NIA-AA revised criteria Àü»ó¿ø(°ºÏ»ï¼ºº´¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 16:05~16:30 ¾ËÃ÷ÇÏÀ̸Ӻ´ ÃÖ½ÅÄ¡·áÁ¦ AD immunotherapy ±èÀº¼ö(°ºÏ»ï¼ºº´¿ø Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 16:30~16:40 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 16:40~17:05 ½Å°æ°úÀû °üÁ¡¿¡¼ º¸´Â ¼ö¸éÁúȯ: ·½¼ö¸éÇൿÀå¾Ö(RBD)¿Í ÇÏÁöºÒ¾ÈÁõÈıº ¼±¿ìÁØ»ó(°ºÏ»ï¼ºº´¿ø ½Å°æ°ú)
±³À°½Ã°£ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 17:05~17:30 À̺ñÀÎÈÄ°úÀû °üÁ¡¿¡¼ º¸´Â ¼ö¸é Áúȯ: Æó¼â¼ö¸é¹«È£Èí(OSA) È«¼®Áø(°ºÏ»ï¼ºº´¿ø À̺ñÀÎÈÄ°ú)
Åä·Ð 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 17:30~17:40 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 17:40~18:05 °¡»óȯ°æÈ°¿ë ºÒ¾ÈÇൿÆò°¡ °³¹ß ¹× ¹ßÀü¹æÇâ ±èÁØÇü(°ºÏ»ï¼ºº´¿ø )
±³À°½Ã°£ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 18:05~18:30 Çѱ¹ ±Ù·ÎÀÚµéÀÇ Á¤½Å°Ç° Á¶¼ºÁØ(°ºÏ»ï¼ºº´¿ø Á¤½Å°Ç°ÀÇÇаú)
Åä·Ð 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 18:30~18:40 ÁúÀÇÀÀ´ä ()
±âŸ 02¿ù 24ÀÏ Çѱ¹ÇÁ·¹½º¼¾ÅÍ 18:40~19:00 Æóȸ»ç ½ÉÁøÇö(»ç°ú³ª¹« Á¤½Å°Ç°ÀÇÇаú)